Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral vs Intravenous Methylprednisolone for MS Relapse
NCT00753792Phase 4Completed
- Sponsor
- Hospital Universitari Germans Trias i Pujol
- Start
- Nov 2008
- Primary completion
- Nov 2010
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of methylprednisolone injection in multiple sclerosis (MS), sponsored by Hospital Universitari Germans Trias i Pujol. Started Nov 2008; status: completed.
02
Drugs
methylprednisolone injection
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT00753792.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00753792.